Revvity, Inc.

RVTY

Revvity, Inc. (RVTY) is a global provider of laboratory testing, diagnostic products, and healthcare solutions. The company focuses on advancing scientific research and medical diagnostics through innovative technologies and comprehensive testing services, supporting healthcare providers and research institutions worldwide.

$117.75 0.00 (0.00%)

Dividend Yield 0.24%

Payout Frequency Quarterly

Dividend History

🎉 Upcoming Dividend

Investors can expect a dividend payout of $0.07 per share, scheduled to be distributed in 14 days on February 6, 2026

Pay Date	Amount	Ex-Date	Record Date
February 6, 2026	$0.07	2026-01-16	2026-01-16
November 7, 2025	$0.07	2025-10-17	2025-10-17
August 8, 2025	$0.07	2025-07-18	2025-07-18
May 9, 2025	$0.07	2025-04-17	2025-04-18
February 7, 2025	$0.07	2025-01-17	2025-01-17
November 8, 2024	$0.07	2024-10-18	2024-10-18
August 9, 2024	$0.07	2024-07-19	2024-07-19
May 10, 2024	$0.07	2024-04-18	2024-04-19
February 9, 2024	$0.07	2024-01-18	2024-01-19
November 10, 2023	$0.07	2023-10-19	2023-10-20
August 11, 2023	$0.07	2023-07-20	2023-07-21
May 12, 2023	$0.07	2023-04-20	2023-04-21
February 10, 2023	$0.07	2023-01-19	2023-01-20
November 11, 2022	$0.07	2022-10-20	2022-10-21
August 12, 2022	$0.07	2022-07-21	2022-07-22
May 13, 2022	$0.07	2022-04-21	2022-04-22
February 11, 2022	$0.07	2022-01-20	2022-01-21
November 12, 2021	$0.07	2021-10-21	2021-10-22
August 6, 2021	$0.07	2021-07-15	2021-07-16
May 7, 2021	$0.07	2021-04-15	2021-04-16
February 12, 2021	$0.07	2021-01-21	2021-01-22
November 6, 2020	$0.07	2020-10-15	2020-10-16
August 7, 2020	$0.07	2020-07-16	2020-07-17
May 8, 2020	$0.07	2020-04-16	2020-04-17
February 7, 2020	$0.07	2020-01-16	2020-01-17
November 8, 2019	$0.07	2019-10-17	2019-10-18
August 9, 2019	$0.07	2019-07-18	2019-07-19
May 10, 2019	$0.07	2019-04-17	2019-04-19
February 8, 2019	$0.07	2019-01-17	2019-01-18
November 9, 2018	$0.07	2018-10-18	2018-10-19
August 10, 2018	$0.07	2018-07-19	2018-07-20
May 10, 2018	$0.07	2018-04-12	2018-04-13
February 9, 2018	$0.07	2018-01-18	2018-01-19
November 10, 2017	$0.07	2017-10-19	2017-10-20
August 10, 2017	$0.07	2017-07-19	2017-07-21
May 10, 2017	$0.07	2017-04-11	2017-04-14
February 10, 2017	$0.07	2017-01-18	2017-01-20
November 10, 2016	$0.07	2016-10-12	2016-10-14
August 10, 2016	$0.07	2016-07-13	2016-07-15
May 10, 2016	$0.07	2016-04-13	2016-04-15
February 10, 2016	$0.07	2016-01-13	2016-01-15
November 10, 2015	$0.07	2015-10-14	2015-10-16
August 10, 2015	$0.07	2015-07-15	2015-07-17
May 11, 2015	$0.07	2015-04-15	2015-04-17
February 6, 2015	$0.07	2015-01-14	2015-01-16
November 7, 2014	$0.07	2014-10-15	2014-10-17
August 8, 2014	$0.07	2014-07-16	2014-07-18
May 9, 2014	$0.07	2014-04-15	2014-04-18
February 7, 2014	$0.07	2014-01-15	2014-01-17
November 8, 2013	$0.07	2013-10-16	2013-10-18
August 9, 2013	$0.07	2013-07-17	2013-07-19
May 10, 2013	$0.07	2013-04-17	2013-04-19
February 8, 2013	$0.07	2013-01-16	2013-01-18
November 9, 2012	$0.07	2012-10-17	2012-10-19
August 10, 2012	$0.07	2012-07-18	2012-07-20
May 11, 2012	$0.07	2012-04-18	2012-04-20
February 10, 2012	$0.07	2012-01-18	2012-01-20
November 11, 2011	$0.07	2011-10-19	2011-10-21
August 12, 2011	$0.07	2011-07-20	2011-07-22
May 13, 2011	$0.07	2011-04-19	2011-04-22
February 11, 2011	$0.07	2011-01-19	2011-01-21
November 12, 2010	$0.07	2010-10-20	2010-10-22
August 13, 2010	$0.07	2010-07-21	2010-07-23
May 7, 2010	$0.07	2010-04-14	2010-04-16
February 12, 2010	$0.07	2010-01-20	2010-01-22
November 13, 2009	$0.07	2009-10-21	2009-10-23
August 7, 2009	$0.07	2009-07-15	2009-07-17
May 8, 2009	$0.07	2009-04-15	2009-04-17
February 6, 2009	$0.07	2009-01-14	2009-01-16
November 7, 2008	$0.07	2008-10-15	2008-10-17
August 8, 2008	$0.07	2008-07-16	2008-07-18
May 9, 2008	$0.07	2008-04-16	2008-04-18
February 8, 2008	$0.07	2008-01-16	2008-01-18
November 9, 2007	$0.07	2007-10-17	2007-10-19
August 10, 2007	$0.07	2007-07-18	2007-07-20
May 11, 2007	$0.07	2007-04-18	2007-04-20
February 9, 2007	$0.07	2007-01-17	2007-01-19
November 10, 2006	$0.07	2006-10-18	2006-10-20
August 11, 2006	$0.07	2006-07-19	2006-07-21
May 12, 2006	$0.07	2006-04-19	2006-04-21
February 10, 2006	$0.07	2006-01-18	2006-01-20
November 11, 2005	$0.07	2005-10-19	2005-10-21
August 12, 2005	$0.07	2005-07-20	2005-07-22
May 13, 2005	$0.07	2005-04-20	2005-04-22
February 11, 2005	$0.07	2005-01-19	2005-01-21
November 12, 2004	$0.07	2004-10-20	2004-10-22
August 13, 2004	$0.07	2004-07-21	2004-07-23
May 14, 2004	$0.07	2004-04-21	2004-04-23
February 5, 2004	$0.07	2004-01-14	2004-01-16

Dividends Summary

Consistent Payer: Revvity, Inc. has rewarded shareholders with 89 dividend payments over the past 22 years.
Total Returned Value: Investors who held RVTY shares during this period received a total of $6.23 per share in dividend income.
Latest Payout: The most recent dividend of $0.07/share was paid 77 days ago, on November 7, 2025.
Yield & Schedule: RVTY currently pays dividends quarterly with an annual yield of 0.24%.
Dividend Growth: Since 2004, the dividend payout has grown by 0.0%, from $0.07 to $0.07.
Dividend Reliability: RVTY has maintained or increased its dividend for 89 consecutive payments.

Company News

Stock Market Today: Nasdaq 100, S&P 500, Dow Jones Futures Lag Ahead Of December CPI Print— JPMorgan, Alphabet, Five9 In Focus (UPDATED)

Benzinga • Rishabh Mishra • January 13, 2026

U.S. stock futures declined on Tuesday ahead of December CPI data release. Major indices were trading lower with the S&P 500 down 0.12% and Nasdaq 100 down 0.19%. Key stocks in focus include Alphabet reaching $4 trillion market value, JPMorgan preparing to report Q4 earnings, Five9 expanding its Google Cloud partnership, and Revvity rising 4.92% ...

GOOG GOOGL AMJB JPM VYLD FIVN

Tech Stocks Rally, Gold Tumbles On US-China Trade Progress: What's Moving Markets Monday?

Benzinga • Piero Cingari • October 27, 2025

Wall Street extended its record-setting streak with major indices hitting all-time highs after a breakthrough in US-China trade negotiations. Trade tensions eased with potential tariff threats averted and promising discussions between diplomatic representatives.

QCOM KDP NEM

Revvity Slashes Outlook As China Policy Deals Diagnostics Blow

Benzinga • Vandana Singh • July 28, 2025

Revvity reported Q2 earnings beating estimates but lowered fiscal year 2025 guidance due to challenging macroeconomic conditions and China's new hospital laboratory reimbursement policy, which is impacting its immunodiagnostics business.

Revvity Q2 Revenue Up 4 Percent

The Motley Fool • Jesterai • July 28, 2025

Revvity reported Q2 2025 financial results with $720 million revenue, exceeding estimates, but experiencing margin compression and slight earnings decline due to tariff pressures and challenging market conditions.

CRISPR Gene Editing Market Surges USD 4.77 in 2025, `Vertex’s Casgevy, AI-Powered OpenCRISPR-1 and Trisomy 21 Breakthrough Fuels Growth

GlobeNewswire Inc. • Towards Healthcare • July 8, 2025

The global CRISPR gene editing market is projected to grow from USD 4.15 billion in 2024 to USD 16.47 billion by 2034, driven by technological advancements, increasing investments, and growing applications in biotechnology and healthcare.

DHR TMO